- document
-
TNO Informatie- en communicatietechnologie (author), van der Waaij, B.D. (author), Siljee, B.I.J. (author), Broekhuijsen, B.J. (author), Ponsioen, C. (author), Maas, A. (author), Aten, R.M. (author), Hoepman, J.H. (author), van Loon, J.H. (author), Smit, M. (author)A method of making a payment uses a first mobile communication device (1) and a second mobile communication device (2), each mobile communication device being provided with a respective near field communication unit (11, 21) and at least one of the mobile communication devices being provided with an input unit (12) for inputting data. The method...patent 2009
- document
-
TNO Informatie- en Communicatietechnologie (author), van der Waaij, B.D. (author), Siljee, B.I.J. (author), Broekhuijsen, B.J. (author), Ponsioen, C. (author), Maas, A. (author), Aten, R.M. (author), Hoepman, J.H. (author), van Loon, J.H. (author), Smit, M. (author)A method of making a payment uses a mobile communication device (1) and a payment card (2), both the mobile communication device (1) and the payment card (2) being provided with a respective near field communication unit (11, 21) and at least the mobile communication device (1) being provided with an input unit (12) for inputting data. The...patent 2009
- document
-
TNO Informatie- en communicatietechnologie (author), van der Waaij, B.D. (author), Siljee, B.I.J. (author), Broekhuijsen, B.J. (author), Ponsioen, C. (author), Maas, A. (author), Aten, R.M. (author), Hoepman, J.H. (author), van Loon, J.H. (author), Smit, M. (author)A method of making a payment uses a mobile communication device (1) and a payment card (2), both the mobile communication device (1) and the payment card (2) being provided with a respective near field communication unit (11, 21) and at least the mobile communication device (1) being provided with an input unit (12) for inputting data. The...patent 2009
- document
-
TNO Kwaliteit van Leven (author), Trion, A. (author), Maat, M.de (author), Jukema, W. (author), Maas, A. (author), Offerman, E. (author), Havekes, L. (author), Szalai, A. (author), Laarse, A.V.D. (author), Princen, H. (author), Emeis, J. (author)We investigated the pleiotropic effects of a calcium antagonist (amlodipine) on early atherosclerosis development in the presence and absence of an HMG-CoA-reductase inhibitor (atorvastatin) in apolipoprotein E*3-Leiden/human C-reactive protein (E3L/CRP) transgenic mice. Male E3L/CRP transgenic mice were fed a cholesterol-containing diet either...article 2006
- document
-
Rezaee, F. (author), Maas, A. (author), de Maat, M.P.M. (author), Verheijen, J.H. (author), Koopman, J. (author), Gaubius instituut TNO (author)Many epidemiological studies suggest that elevated plasma fibrinogen concentrations form one of the most important independent risk factors in blood for cardiovascular disease and particularly atherosclerosis in humans. To clarify the effect of genetic factors, diets and their interactions on plasma fibrinogen concentrations, we examined plasma...article 2002
- document
-
Collen, A. (author), Maas, A. (author), Kooistra, T. (author), Lupu, F. (author), Grimbergen, J. (author), Haas, F.J.L.M. (author), Biesma, D.H. (author), Koolwijk, P. (author), Koopman, J. (author), van Hinsbergh, V.W.M. (author), Gaubius instituut TNO (author)A congenital dysfibrinogenemia, fibrinogenNieuwegein, was discovered in a young man without any thromboembolic complications or bleeding. A homozygous insertion of a single nucleotide (C) in codon Aα 453 (Pro) introduced a stop codon at position 454, which resulted in the deletion of the Carboxyl-terminal segment Aα 454-610. The ensuing unpaired...article 2001
- document
-
Koopman, J. (author), Maas, A. (author), Rezaee, F. (author), Havekes, L. (author), Verheijen, J. (author), Gijbels, M. (author), Haverkate, F. (author), Gaubius Instituut TNO (author)Atherosclerosis is a multifactorial disease that is influenced by both genetic and environmental factors. Recent epidemiological studies have shown that the combination of elevated VLDL/LDL concentrations and elevated fibrinogen levels results in a strong increase of the risk for cardiovascular disease as compared to the individual risk factors....article 1997